Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.

The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management. Pairing twiist™ with Senseonics’ ...

Supermodel Bambi Northwood-Blyth wears a Dexcom glucose monitor. So does your next-door neighbor with Type 2 diabetes and ...

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year.

Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) devices, halving monthly costs. Read more at straitstimes.com. Read more at ...

ABSTRACT: Microfluidic wearables move microliter biofluids across soft, low-impedance interfaces and into stable transducers on skin, enabling time-stamped chemistry without pumps. In this review ...

Stelo by Dexcom is a wearable glucose biosensor that brings continuous glucose monitoring into the consumer wellness space, aimed at adults who are not using insulin but still want detailed glucose ...